SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kalkanli, S.
Right arrow Articles by Muftuoglu, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalkanli, S.
Right arrow Articles by Muftuoglu, E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Deep Vein Thrombosis
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Factor V Leiden Mutation in Venous Thrombosis in Southeast Turkey

Sevgi Kalkanli, PhD

Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey, sgkalkanli{at}yahoo.com

Orhan Ayyildiz, MD

Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey

Naci Tiftik, MD

Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey

Sabri Batun, PhD

Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey

Abdurrahman Isikdogan, MD

Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey

Hakan Ince, PhD

Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey

Selahaddin Tekes, PhD

Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey

Ekrem Muftuoglu, MD

Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey

Venous thrombosis (VT) is a common disease, with an annual incidence in the general population of approximately 1 per 1,000. Factor V Leiden mutation (G1691A) (FVL) is the most common risk factor in venous thrombosis. The prevalence of FVL for thrombosis varies greatly in different regions of the world. FVL mutation has been identified both by conventional method and fluorescence resonance energy transfer (FRET) with the LightCycler. Sixty-one patients with VT, different in age and sex, were consecutively entered into this study to assess the prevalence of FVL in VT in southeast Turkey. FVL mutation was found in 24.6% (15/61). Fourteen individuals were heterozygous and 1 homozygous, a rate of 22.9% and 1.6%, respectively. In conclusion, the authors suggest that FVL mutation is common in patients with venous thrombosis in southeast Turkey.

Angiology, Vol. 57, No. 2, 193-196 (2006)
DOI: 10.1177/000331970605700209


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement